Biomarkers for Nonexudative Age-Related Macular Degeneration and Relevance for Clinical Trials: A Systematic Review
ConclusionThis systematic review supports the use of structural and functional biomarkers in early AMD and intermediate AMD, which are more reproducible and less invasive than the other classes of biomarkers described. The use of deep learning and combinational algorithms will gain increasing importance in future clinical trials of nonexudative AMD.
Source: Molecular Diagnosis and Therapy - Category: Molecular Biology Source Type: research
More News: Age-Related Macular Degeneration (AMD) | Blindness | Clinical Trials | Learning | Molecular Biology | Opthalmology | Science | Study | Universities & Medical Training | Vitamin A